Correlation Between Viridian Therapeutics and Revance
Can any of the company-specific risk be diversified away by investing in both Viridian Therapeutics and Revance at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viridian Therapeutics and Revance into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viridian Therapeutics and Revance, you can compare the effects of market volatilities on Viridian Therapeutics and Revance and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viridian Therapeutics with a short position of Revance. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viridian Therapeutics and Revance.
Diversification Opportunities for Viridian Therapeutics and Revance
-0.43 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Viridian and Revance is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Viridian Therapeutics and Revance in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Revance and Viridian Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viridian Therapeutics are associated (or correlated) with Revance. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Revance has no effect on the direction of Viridian Therapeutics i.e., Viridian Therapeutics and Revance go up and down completely randomly.
Pair Corralation between Viridian Therapeutics and Revance
Given the investment horizon of 90 days Viridian Therapeutics is expected to generate 0.34 times more return on investment than Revance. However, Viridian Therapeutics is 2.97 times less risky than Revance. It trades about -0.19 of its potential returns per unit of risk. Revance is currently generating about -0.07 per unit of risk. If you would invest 2,339 in Viridian Therapeutics on August 24, 2024 and sell it today you would lose (377.00) from holding Viridian Therapeutics or give up 16.12% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Viridian Therapeutics vs. Revance
Performance |
| Timeline |
| Viridian Therapeutics |
| Revance |
Viridian Therapeutics and Revance Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Viridian Therapeutics and Revance
The main advantage of trading using opposite Viridian Therapeutics and Revance positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viridian Therapeutics position performs unexpectedly, Revance can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Revance will offset losses from the drop in Revance's long position.| Viridian Therapeutics vs. Nuvalent | Viridian Therapeutics vs. Arcellx | Viridian Therapeutics vs. Vaxcyte | Viridian Therapeutics vs. Crinetics Pharmaceuticals |
| Revance vs. DiaMedica Therapeutics | Revance vs. Akero Therapeutics | Revance vs. Nuvalent | Revance vs. Immunocore Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| CEOs Directory Screen CEOs from public companies around the world |